A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population

Danni Shi; Pu Li; Lan Ma; Dongyan Zhong; Haiyan Chu; Fu Yan; Qiang Lv; Chao Qin; Wei Wang; Meilin Wang; Na Tong; Zhengdong Zhang; Changjun Yin

doi:10.1371/journal.pone.0046566

Loading metrics

Open Access

Peer-reviewed

Research Article

A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population

Danni Shi ,

Contributed equally to this work with: Danni Shi, Pu Li, Lan Ma

Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯
Pu Li ,

Contributed equally to this work with: Danni Shi, Pu Li, Lan Ma

Affiliation Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯
Lan Ma ,

Contributed equally to this work with: Danni Shi, Pu Li, Lan Ma

Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Dongyan Zhong,

Affiliations Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯
Haiyan Chu,

Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Fu Yan,

Affiliation Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Qiang Lv,

Affiliation Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯
Chao Qin,

Affiliation Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯
Wei Wang,

Affiliation Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Meilin Wang,

Affiliations Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯
Na Tong,

Affiliation Department of Occupational Medicine and Environmental Health, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯
Zhengdong Zhang ,

* E-mail: drzdzhang@gmail.com (ZZ); drcjyin@gmail.com (CY)

Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯
Changjun Yin

* E-mail: drzdzhang@gmail.com (ZZ); drcjyin@gmail.com (CY)

Affiliation Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯

A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population

Danni Shi,
Pu Li,
Lan Ma,
Dongyan Zhong,
Haiyan Chu,
Fu Yan,
Qiang Lv,
Chao Qin,
Wei Wang,
Meilin Wang

Published: October 30, 2012
https://doi.org/10.1371/journal.pone.0046566

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Renal cell carcinoma
Is the Subject Area "Renal cell carcinoma" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Variant genotypes
Is the Subject Area "Variant genotypes" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.